Archives for June 19, 2014

← 2014

Dispatches from DIA

Global biosimilar regulations diverging, experts say

By Zachary Brennan

As biopharma companies look to take advantage of a biosimilar market set to exceed $3.7bn by 2016, experts say the different regulations governing the follow-on biologics may be an issue as the markets become more developed.